Paul S. Mischel

40.6k total citations · 3 hit papers
218 papers, 19.5k citations indexed

About

Paul S. Mischel is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Paul S. Mischel has authored 218 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Molecular Biology, 91 papers in Cancer Research and 74 papers in Genetics. Recurrent topics in Paul S. Mischel's work include Glioma Diagnosis and Treatment (71 papers), Cancer Genomics and Diagnostics (41 papers) and Cancer, Hypoxia, and Metabolism (33 papers). Paul S. Mischel is often cited by papers focused on Glioma Diagnosis and Treatment (71 papers), Cancer Genomics and Diagnostics (41 papers) and Cancer, Hypoxia, and Metabolism (33 papers). Paul S. Mischel collaborates with scholars based in United States, Japan and United Kingdom. Paul S. Mischel's co-authors include Timothy F. Cloughesy, Linda M. Liau, Webster K. Cavenee, Steve Horvath, Stanley F. Nelson, Kenta Masui, Harry V. Vinters, Whitney B. Pope, Albert Lai and Vineet Bafna and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Paul S. Mischel

213 papers receiving 19.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma

2006 1.1k citations Paul S. Mischel et al. profile →
Gene Expression Profiling of Gliomas Strongly Predicts Survival

2004 563 citations William A. Freije, F. Edmundo Castro-Vargas et al. Cancer Research profile →
Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers

2020 260 citations Hoon Kim, Kristen M. Turner et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Paul S. Mischel	10.5k	6.0k	5.9k	4.5k	2.2k	218	19.5k
C. David James	10.4k 1.0×	7.8k 1.3×	4.8k 0.8×	4.7k 1.0×	1.8k 0.8×	237	19.5k
Keith L. Ligon	11.4k 1.1×	7.2k 1.2×	5.2k 0.9×	3.7k 0.8×	1.9k 0.8×	248	21.3k
Santosh Kesari	7.6k 0.7×	5.9k 1.0×	4.4k 0.7×	4.3k 0.9×	1.5k 0.7×	440	18.1k
Gregory J. Riggins	11.7k 1.1×	4.8k 0.8×	5.3k 0.9×	4.1k 0.9×	1.3k 0.6×	117	18.4k
Howard A. Fine	9.1k 0.9×	9.6k 1.6×	4.9k 0.8×	5.2k 1.2×	1.6k 0.7×	235	21.3k
David Zagzag	7.8k 0.7×	5.9k 1.0×	5.3k 0.9×	3.4k 0.7×	1.6k 0.7×	258	19.3k
Eric C. Holland	12.2k 1.2×	10.1k 1.7×	5.8k 1.0×	6.3k 1.4×	4.7k 2.1×	230	25.7k
Jann N. Sarkaria	9.5k 0.9×	4.8k 0.8×	3.5k 0.6×	5.4k 1.2×	1.1k 0.5×	325	16.2k
Monika E. Hegi	9.5k 0.9×	12.9k 2.2×	6.1k 1.0×	4.2k 0.9×	2.0k 0.9×	155	20.8k
Manfred Westphal	5.9k 0.6×	8.0k 1.3×	3.6k 0.6×	3.1k 0.7×	1.3k 0.6×	434	18.6k

Countries citing papers authored by Paul S. Mischel

Since Specialization

Citations

This map shows the geographic impact of Paul S. Mischel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul S. Mischel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul S. Mischel more than expected).

Fields of papers citing papers by Paul S. Mischel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul S. Mischel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul S. Mischel. The network helps show where Paul S. Mischel may publish in the future.

Co-authorship network of co-authors of Paul S. Mischel

This figure shows the co-authorship network connecting the top 25 collaborators of Paul S. Mischel. A scholar is included among the top collaborators of Paul S. Mischel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul S. Mischel. Paul S. Mischel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Noorani, Imran, et al.. (2025). Extrachromosomal DNA: shaping the evolutionary dynamics of cancer. Trends in cancer. 11(9). 901–916. 1 indexed citations

Luebeck, Jens, Katerina Kraft, Shu Zhang, et al.. (2025). Reconstructing the three-dimensional architecture of extrachromosomal DNA with ec3D. Nature Communications. 17(1). 894–894.

Luebeck, Jens, Soyeon Kim, Hoon Kim, et al.. (2024). 13. AmpliconSuite: Analyzing focal amplifications in cancer genomes. Cancer Genetics. 286-287. S5–S5.

Rose, John C., et al.. (2023). Extrachromosomal DNA: Biogenesis and Functions in Cancer. 8(1). 135–153. 1 indexed citations

Masui, Kenta & Paul S. Mischel. (2023). Metabolic and epigenetic reprogramming in the pathogenesis of glioblastoma: Toward the establishment of “metabolism‐based pathology”. Pathology International. 73(11). 533–541. 5 indexed citations

Bakhoum, Mathieu F., Jasmine H. Francis, Albert S. Agustinus, et al.. (2021). Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression. Nature Communications. 12(1). 5402–5402. 35 indexed citations

Masui, Kenta, Hiroaki Honda, Yoshihiro Muragaki, et al.. (2020). Dual Regulation of Histone Methylation by mTOR Complexes Controls Glioblastoma Tumor Cell Growth via EZH2 and SAM. Molecular Cancer Research. 18(8). 1142–1152. 36 indexed citations

Park, Pyoung Hwa, Tomomi M. Yamamoto, Hua Li, et al.. (2019). Amplification of the Mutation-Carrying BRCA2 Allele Promotes RAD51 Loading and PARP Inhibitor Resistance in the Absence of Reversion Mutations. Molecular Cancer Therapeutics. 19(2). 602–613. 20 indexed citations

Agnihotri, Sameer, Brian Golbourn, Xi Huang, et al.. (2016). PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. Cancer Research. 76(16). 4708–4719. 109 indexed citations

10.

Li, Sichen, Reshmi Chowdhury, Fei Liu, et al.. (2014). Tumor-Suppressive miR148a Is Silenced by CpG Island Hypermethylation in IDH1 -Mutant Gliomas. Clinical Cancer Research. 20(22). 5808–5822. 29 indexed citations

11.

Wykosky, Jill, Jingjing Hu, German G. Gomez, et al.. (2014). A Urokinase Receptor–Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR Glioblastoma. Cancer Research. 75(2). 394–404. 43 indexed citations

12.

Woerner, B. Mark, Jingqin Luo, Erin Jackson, et al.. (2011). Suppression of G-protein–Coupled Receptor Kinase 3 Expression Is a Feature of Classical GBM That Is Required for Maximal Growth. Molecular Cancer Research. 10(1). 156–166. 33 indexed citations

13.

Liu, Yue, Fei Ye, Kazunari Yamada, et al.. (2011). Autocrine Endothelin-3/Endothelin Receptor B Signaling Maintains Cellular and Molecular Properties of Glioblastoma Stem Cells. Molecular Cancer Research. 9(12). 1668–1685. 30 indexed citations

14.

Agnihotri, Sameer, Amparo Wolf, Diana M. Muñoz, et al.. (2011). A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas. The Journal of Experimental Medicine. 208(4). 689–702. 65 indexed citations

15.

Lai, Albert, Anh Tran, Phioanh L. Nghiemphu, et al.. (2010). Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 29(2). 142–148. 353 indexed citations

16.

Yoshimoto, Koji, Julie Dang, Shaojun Zhu, et al.. (2008). Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples. Clinical Cancer Research. 14(2). 488–493. 81 indexed citations

17.

Tso, Cho-Lea, William A. Freije, Allen Day, et al.. (2006). Distinct Transcription Profiles of Primary and Secondary Glioblastoma Subgroups. Cancer Research. 66(1). 159–167. 152 indexed citations

18.

Lu, Kan, Shaojun Zhu, Ederlyn Q. Dia, et al.. (2006). Mammalian Target of Rapamycin Inhibition Promotes Response to Epidermal Growth Factor Receptor Kinase Inhibitors in PTEN-Deficient and PTEN-Intact Glioblastoma Cells. Cancer Research. 66(16). 7864–7869. 179 indexed citations

19.

Tso, Cho-Lea, Peter Shintaku, James Chen, et al.. (2006). Primary Glioblastomas Express Mesenchymal Stem-Like Properties. Molecular Cancer Research. 4(9). 607–619. 184 indexed citations

20.

Freije, William A., F. Edmundo Castro-Vargas, Zixing Fang, et al.. (2004). Gene Expression Profiling of Gliomas Strongly Predicts Survival. Cancer Research. 64(18). 6503–6510. 563 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact